STUDIES ON MANNOSE-BINDING-PROTEIN (MBP) ; WITH SPECIAL REFERENCE TO COMPLEMENT ACTIVATION AND REGULATION,AND ITS DEPOSITION IN RENAL TISSUES

甘露糖结合蛋白(MBP)的研究;

基本信息

  • 批准号:
    07457176
  • 负责人:
  • 金额:
    $ 4.8万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

Human mannose-binding-protein (MBP) is a serum lectin involving in the host defense via the complement activation. Thus, this complement activation is called lectin pathway. Recently, it was shown that the lectin pathway was intiated by a novel serine protease, termed MBP-associated serine protease (MASP), of which overall structure is similar to Cls or Clr. The present studies dealt with the identification of a serum protein possibly involving in the regulation of the MASP.(1) We identified in serum a complex consisting of MBP,MASP and alpha2-macroglobulin.(2) The binding order of these proteins was defined to be MBP-MASP-alpha2-macroglobulin by sandwich ELISA systems with two independent antibodies.(3) The binding of MBP with MASP was Ca^<2+> dependent and reversible, while that between MASP and alpha2-macroglobulin was covalent and irreversible.(4) The esterolytic activity of MASP was definitely inhibited by binding with alpha2-macroglobulin.(5) There were two forms of MASP in serum, one binding with MBP and/or alpha2-macroglobulin and the other free from them. The levels of MASP in serum was much higher than those of MBP.Ontogenic examination of MASP in serum disclosed that the level of MASP was high in infancy and declined with advance of ages of which tendency was quite similar to that of MBP.Alfa2-macroglobulin is known to be a phylogenetically quite old protease-inhibitor with broad specificity. MBP is also known to be an old protein, the animal lectin. Thus, it is quite retinal that the lectin pathway, an old complement pathway, which remains and functions in the higher animals, is regulated by an old protease-inhibitor, alpha2-macroglobulin. The levels of MBP and MASP are higher in infancy and decline in advance of ages, indicating that the lectin pathway fully functions in the early ages when antibodies are not sufficiently emerged.
人甘露糖结合蛋白(MBP)是一种血清凝集素,通过激活补体参与宿主防御。因此,这种补体激活被称为凝集素途径。最近,研究表明凝集素途径是由一种新的丝氨酸蛋白酶启动的,称为MBP相关丝氨酸蛋白酶(MASP),其整体结构类似于Cls或Clr。本研究涉及可能参与MASP调节的血清蛋白的鉴定。(1)我们在血清中鉴定了由MBP、MASP和α 2-巨球蛋白组成的复合物。(2)通过具有两个独立抗体的夹心ELISA系统将这些蛋白质的结合顺序定义为MBP-MASP-α 2-巨球蛋白。(3)MBP与MASP的结合是Ca^<2+>依赖的、可逆的,而MASP与α 2-巨球蛋白的结合是共价的、不可逆的。(4)MASP的酯溶解活性通过与α 2-巨球蛋白结合而被明确抑制。(5)血清中有两种形式的MASP,一种与MBP和/或α 2-巨球蛋白结合,另一种不与它们结合。血清MASP水平明显高于MBP,MASP在婴儿期水平较高,随年龄增长而下降,其变化趋势与MBP相似。α 2-巨球蛋白是一种具有广泛特异性的蛋白酶抑制剂。MBP也被认为是一种古老的蛋白质,即动物凝集素。因此,很明显,凝集素途径(一种古老的补体途径)在高等动物中仍然存在并发挥作用,它受到一种古老的蛋白酶抑制剂α 2-巨球蛋白的调节。MBP和MASP的水平在婴儿期较高,随着年龄的增长而下降,表明凝集素途径在抗体未充分出现的早期充分发挥作用。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Terai, I.: "α_2-Mavzoglobulin binds to and inhibits manmose-binding pnotein-asscciated serime protacse" International Immunology. 7 (10). 1579-1584 (1995)
Terai,I.:“α_2-Mavzoglobulin 结合并抑制甘露糖结合蛋白相关丝氨酸蛋白酶”,《国际免疫学》7 (10) 1579-1584 (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Terai I.: "α_2-macroglobulin binds and inhibits mannose-binding protein associated serine protease(MASP)" International Immunology. 7(10). 1579-1584 (1995)
Terai I.:“α_2-巨球蛋白结合并抑制甘露糖结合蛋白相关丝氨酸蛋白酶(MASP)”国际免疫学 7(10)1579-1584(1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
小林 邦彦: "粘膜と感染防御" Lab-Topics. 16(2). 1-2 (1995)
小林邦彦:“粘膜和感染防御”实验室主题 16(2) (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Terai,I.,Kobayasi,K.et al.: "α2-macroglobulinbinds to and inhibits mannose-binding protein-associated serine protease." Internationol Immunology. 7. 1579-1584 (1995)
Terai, I., Kobayasi, K. 等人:“α2-巨球蛋白结合并抑制甘露糖结合蛋白相关的丝氨酸蛋白酶。”国际免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Terai, I., Kobayashi, K., Matsushita M., Fujita, T.and Matsuno, K.: "alpha2-macroglobulin binds and inhibits mannose-binding protein associated serine protease (MASP)" International Immunology. 7 (10). 1579-1584 (1995)
Terai, I.、Kobayashi, K.、Matsushita M.、Fujita, T. 和 Matsuno, K.:“α2-巨球蛋白结合并抑制甘露糖结合蛋白相关丝氨酸蛋白酶 (MASP)”国际免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KOBAYASHI Kunihiko其他文献

KOBAYASHI Kunihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KOBAYASHI Kunihiko', 18)}}的其他基金

Study on dynamics in the prevention of root fractures in abutment teeth of the fixed partial denture
固定局部义齿基牙预防牙根折裂的动力学研究
  • 批准号:
    19592221
  • 财政年份:
    2007
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AIE-75 gene : with special reference to the differentiation of mucosal epithelial cells and the regulation of gene expression
AIE-75基因:特别涉及粘膜上皮细胞的分化和基因表达的调控
  • 批准号:
    14370237
  • 财政年份:
    2002
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study of a novel autoantigen related to autoimmune enteropathy with renal tubular dysfunction
一种与肾小管功能障碍自身免疫性肠病相关的新型自身抗原的研究
  • 批准号:
    12470162
  • 财政年份:
    2000
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Designing an Intercultural Syllabus
设计跨文化教学大纲
  • 批准号:
    11610301
  • 财政年份:
    1999
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study on Abutment Forms and materials of Restorations utilizing Adhesion
粘合修复体基台形式和材料的研究
  • 批准号:
    11671919
  • 财政年份:
    1999
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on human osteopontin : isolation and characterization of osteopontin in milk and serum.
人骨桥蛋白的研究:牛奶和血清中骨桥蛋白的分离和表征。
  • 批准号:
    09557062
  • 财政年份:
    1997
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
STUDIES ON CALCIUM BINDING PROTEIN,OSTEOPONTIN,ITS DIAGNOSTIC AND THERAPEUTIC APPLICATION FOR BONE DISORDERS.
钙结合蛋白、骨桥蛋白的研究及其在骨疾病诊断和治疗中的应用。
  • 批准号:
    07557061
  • 财政年份:
    1995
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
A study on Adhesion Mechanism between Adhesive resin and Dentin
粘接树脂与牙本质粘接机理的研究
  • 批准号:
    06671938
  • 财政年份:
    1994
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
A Study of Attrition Caused by Various Restorative Materials
各种修复材料引起的磨损的研究
  • 批准号:
    03670907
  • 财政年份:
    1991
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Human serum mannose-binding protein: its function and a possible application to the clinical use.
人血清甘露糖结合蛋白:其功能和临床应用的可能。
  • 批准号:
    03454505
  • 财政年份:
    1991
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigating the role of complement component 5a in ANCA-associated vasculitis
研究补体成分 5a 在 ANCA 相关血管炎中的作用
  • 批准号:
    MR/Y000854/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Fellowship
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
  • 批准号:
    10751872
  • 财政年份:
    2024
  • 资助金额:
    $ 4.8万
  • 项目类别:
NSF Convergence Accelerator, Track M: TANDEM: Tensegrity-based Assistive aND rehabilitation Exosuits to complement human bioMechanics
NSF 融合加速器,轨道 M:TANDEM:基于张拉整体的辅助和康复外装,以补充人体生物力学
  • 批准号:
    2344385
  • 财政年份:
    2024
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Standard Grant
Development of a novel oral vaccine for fish: Synergy of chitosan nano particle and complement-mediated opsonization
新型鱼类口服疫苗的开发:壳聚糖纳米颗粒与补体介导的调理作用的协同作用
  • 批准号:
    24K17960
  • 财政年份:
    2024
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Crosstalk between purinergic signaling and the complement system in sepsis-induced immunosuppression.
脓毒症引起的免疫抑制中嘌呤能信号传导与补体系统之间的串扰。
  • 批准号:
    23H03013
  • 财政年份:
    2023
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
  • 批准号:
    10629550
  • 财政年份:
    2023
  • 资助金额:
    $ 4.8万
  • 项目类别:
Lung-derived complement in pneumonia
肺炎中的肺源性补体
  • 批准号:
    10568567
  • 财政年份:
    2023
  • 资助金额:
    $ 4.8万
  • 项目类别:
Complement Resistance Acquired During Acute to Persistent Rubulavirus Infection
急性至持续性风疹病毒感染期间获得的补体耐药性
  • 批准号:
    10645486
  • 财政年份:
    2023
  • 资助金额:
    $ 4.8万
  • 项目类别:
Defining the impact of complement inhibition by tick saliva in tick-borne virus evolution and adaptive immune responses in murine models of infection
定义蜱唾液抑制补体对蜱传病毒进化和小鼠感染模型适应性免疫反应的影响
  • 批准号:
    10535945
  • 财政年份:
    2023
  • 资助金额:
    $ 4.8万
  • 项目类别:
Inhibition of Complement Pathways with VCP As A Treatment For Alzheimer's Disease
VCP 抑制补体途径治疗阿尔茨海默病
  • 批准号:
    10602757
  • 财政年份:
    2023
  • 资助金额:
    $ 4.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了